For Sun Pharma, its investment in speciality business is paying off, as it is becoming a driver of growth for the company’s US business. Cipla’s ‘One India’ strategy, focusing on branded prescription, trade generics and consumer health brands, is leading to continued core portfolio momentum across businesses.
JSW Infrastructure shares debut at 20% premium over IPO price
JSW Infrastructure has priced the issue in the range of Rs 113-119 per share. The IPO, which is entirely a fresh equity issue of Rs